Potential Interactions Between Strattera (Atomoxetine) and Lexapro (Escitalopram)
Introduction to Interactions
- The combination of atomoxetine and escitalopram may lead to increased escitalopram elimination, potentially reducing its efficacy, and requires careful monitoring for potential serotonergic effects 1, 2
Pharmacokinetic Interactions
- According to the French Association for the Study of the Liver, protease inhibitors can increase the elimination of escitalopram, leading to lower plasma concentrations and potentially reduced efficacy 1
Pharmacodynamic Interactions
- The American Academy of Child and Adolescent Psychiatry advises caution when combining two medications that may affect serotonin levels due to the risk of serotonin syndrome 2
- Symptoms of serotonin syndrome include mental status changes, neuromuscular hyperactivity, and autonomic hyperactivity 2
Clinical Management Recommendations
- If the combination is clinically necessary, start the second medication at a low dose and increase slowly while monitoring for adverse effects 2
- Monitor closely for symptoms of serotonin syndrome, especially in the first 24-48 hours after initiating therapy or changing doses 2
- Be aware that escitalopram's efficacy may be reduced when used with atomoxetine due to increased elimination 1
- Consider monitoring for mental status changes, neuromuscular symptoms, and autonomic nervous system effects 2
- The combination should be avoided in patients with a history of seizures, as both medications can lower the seizure threshold 2
Special Considerations
- If a patient is taking this combination and experiences reduced efficacy of escitalopram, dosage adjustments may be necessary 1, 2
- Neither medication should be combined with monoamine oxidase inhibitors (MAOIs) due to significantly increased risk of serotonin syndrome 2
- Be aware of potential discontinuation syndrome if escitalopram is stopped abruptly 2